These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22220565)

  • 1. Histomorphometric and immunohistochemical analysis of human maxillary sinus-floor augmentation using porous β-tricalcium phosphate for dental implant treatment.
    Miyamoto S; Shinmyouzu K; Miyamoto I; Takeshita K; Terada T; Takahashi T
    Clin Oral Implants Res; 2013 Aug; 24 Suppl A100():134-8. PubMed ID: 22220565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localisation of osteogenic and osteoclastic cells in porous beta-tricalcium phosphate particles used for human maxillary sinus floor elevation.
    Zerbo IR; Bronckers AL; de Lange G; Burger EH
    Biomaterials; 2005 Apr; 26(12):1445-51. PubMed ID: 15482833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological evaluation of maxillary sinus floor augmentation with recombinant human growth and differentiation factor-5-coated β-tricalcium phosphate: results of a multicenter randomized clinical trial.
    Stavropoulos A; Becker J; Capsius B; Açil Y; Wagner W; Terheyden H
    J Clin Periodontol; 2011 Oct; 38(10):966-74. PubMed ID: 21797917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study.
    Kurkcu M; Benlidayi ME; Cam B; Sertdemir Y
    J Oral Implantol; 2012 Sep; 38 Spec No():519-26. PubMed ID: 23072285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta-tricalcium phosphate particles with varying porosity on osteogenesis after sinus floor augmentation in humans.
    Knabe C; Koch C; Rack A; Stiller M
    Biomaterials; 2008 May; 29(14):2249-58. PubMed ID: 18289665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a pilot study in the Goettingen miniature pig comparing autogenous bone and rhGDF-5.
    Gruber RM; Ludwig A; Merten HA; Pippig S; Kramer FJ; Schliephake H
    Clin Oral Implants Res; 2009 Feb; 20(2):175-82. PubMed ID: 19077151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of autogenous bone and beta-tricalcium phosphate in maxillary sinus lifting: histomorphometric study and immunohistochemical assessment of RUNX2 and VEGF.
    Pereira RS; Gorla LF; Boos FBJD; Okamoto R; Garcia Júnior IR; Hochuli-Vieira E
    Int J Oral Maxillofac Surg; 2017 Apr; 46(4):503-510. PubMed ID: 28185708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amount of newly formed bone in sinus grafting procedures depends on tissue depth as well as the type and residual amount of the grafted material.
    Artzi Z; Kozlovsky A; Nemcovsky CE; Weinreb M
    J Clin Periodontol; 2005 Feb; 32(2):193-9. PubMed ID: 15691351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic and histometric evaluation of bovine cancellous bone and beta-tricalcium phosphate 45 months after grafting in maxillary sinus.
    Khatiblou F
    J Oral Implantol; 2011 Dec; 37(6):727-33. PubMed ID: 20942658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ridge augmentation and maxillary sinus grafting with a biphasic calcium phosphate: histologic and histomorphometric observations.
    Friedmann A; Dard M; Kleber BM; Bernimoulin JP; Bosshardt DD
    Clin Oral Implants Res; 2009 Jul; 20(7):708-14. PubMed ID: 19453566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological and Histomorphometrical Determination of the Biogradation of β-Tricalcium Phosphate Granules in Maxillary Sinus Floor Augmentation: A Prospective Observational Study.
    Okada T; Kanai T; Tachikawa N; Munakata M; Kasugai S
    Implant Dent; 2017 Apr; 26(2):275-283. PubMed ID: 28301385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Human Clinical, Histological, Histomorphometrical, and Radiographical Study on Biphasic HA-Beta-TCP 30/70 in Maxillary Sinus Augmentation.
    Mangano C; Sinjari B; Shibli JA; Mangano F; Hamisch S; Piattelli A; Perrotti V; Iezzi G
    Clin Implant Dent Relat Res; 2015 Jun; 17(3):610-8. PubMed ID: 24004190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histomorphometry of human sinus floor augmentation using a porous beta-tricalcium phosphate: a prospective study.
    Zerbo IR; Zijderveld SA; de Boer A; Bronckers AL; de Lange G; ten Bruggenkate CM; Burger EH
    Clin Oral Implants Res; 2004 Dec; 15(6):724-32. PubMed ID: 15533134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic and histomorphometric assessment of sinus-floor augmentation with beta-tricalcium phosphate alone or in combination with pure-platelet-rich plasma or platelet-rich fibrin: A randomized clinical trial.
    Cömert Kılıç S; Güngörmüş M; Parlak SN
    Clin Implant Dent Relat Res; 2017 Oct; 19(5):959-967. PubMed ID: 28745027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical and histological case series study on calcium sulfate for maxillary sinus floor augmentation and delayed placement of dental implants.
    Dasmah A; Hallman M; Sennerby L; Rasmusson L
    Clin Implant Dent Relat Res; 2012 Apr; 14(2):259-65. PubMed ID: 19843103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphometric and histomorphometric evaluations of high-purity macro/microporous beta-tricalcium phosphate in maxillary sinus floor elevation: preliminary results on a retrospective, multi-center, observational study.
    Fujita A; Fukumoto C; Hasegawa T; Sawatani Y; Kawamata H
    BMC Oral Health; 2021 Sep; 21(1):448. PubMed ID: 34530808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone formation with a biphasic calcium phosphate combined with fibrin sealant in maxillary sinus floor elevation for delayed dental implant.
    Wagner W; Wiltfang J; Pistner H; Yildirim M; Ploder B; Chapman M; Schiestl N; Hantak E
    Clin Oral Implants Res; 2012 Sep; 23(9):1112-7. PubMed ID: 22892064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histomorphometric analysis of maxillary sinus augmentation using an alloplast bone substitute.
    Kolerman R; Goshen G; Joseph N; Kozlovsky A; Shetty S; Tal H
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1835-43. PubMed ID: 22793956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive transcrestal sinus floor elevation with deproteinized bovine bone or β-tricalcium phosphate: a multicenter, double-blind, randomized, controlled clinical trial.
    Trombelli L; Franceschetti G; Stacchi C; Minenna L; Riccardi O; Di Raimondo R; Rizzi A; Farina R
    J Clin Periodontol; 2014 Mar; 41(3):311-9. PubMed ID: 24325663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-month histological analysis on maxillary sinus augmentation with and without use of collagen membranes over the osteotomy window: randomized clinical trial.
    Barone A; Ricci M; Grassi RF; Nannmark U; Quaranta A; Covani U
    Clin Oral Implants Res; 2013 Jan; 24(1):1-6. PubMed ID: 22151577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.